arrow
G

G. V. Siva Prasad

Islamic University College
H指数:10
被引数:338

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RETRACTION: RetraTheoretical investigation of the adsorption performance of Au-functionalized MoTe2 nanosheets for sensing S containing hydroxymethanesulfonate and thiophenol molecules

撤回:关于Au功能化MoTe2纳米片对含硫羟甲磺酸盐和噻吩酚分子的吸附性能的理论研究

2025-12-010
PRE
Natural Bioactive Compounds as Modulators of Autophagy: A Herbal Approach to the Management of Neurodegenerative Diseases

天然生物活性化合物作为自噬调节剂:管理神经退行性疾病的草药方法

2025-07-290
PRE
The drug discovery candidate for targeting PARP1 with Onosma. Dichroantha compounds in triple-negative breast cancer: A virtual screening and molecular dynamic simulation

以Onosma Dichroantha化合物为靶向PARP1的药物发现候选物:三阴性乳腺癌的虚拟筛选与分子动力学模拟

2025-06-020
PRE
Regional burden, trends, and future projections of chronic kidney disease due to type 2 diabetes mellitus in South Asia: insights from the global burden of disease study (1990-2021) and ARIMA forecasting

南亚地区2型糖尿病导致的慢性肾脏疾病的区域负担、趋势及未来预测:全球疾病负担研究(1990-2021年)与ARIMA预测的启示

2025-05-120
OA
Falls among geriatric cancer patients: a systematic review and meta-analysis of prevalence and risk across cancer types
2025-03-150
OAAI
Mortality Projections, Regional Disparities in the Burden of Neonatal Disorders, and the Status of Achieving SDG Targets by 2030 in South Asia: Insights from the Global Burden of Disease Study 2021
2025-03-130
OAAI
Assessing the impact of electronic nicotine delivery systems on chronic obstructive pulmonary disease: A systematic review and meta-analysis
2025-03-010
PRE
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis

学生接受Mpox疫苗的患病率: 系统回顾和荟萃分析

2025-02-130
OAAI
Ophthalmic Manifestations of the Mpox Virus: A Systematic Review and Meta-analysis
2025-02-060
PRE
Trends and projections of type 2 diabetes mellitus in South Asia: a three-decade analysis and forecast through 2031 using global burden of disease study (1990 - 2021)

南亚2型糖尿病的趋势与预测:基于全球疾病负担研究(1990-2021)的三十年分析与至2031年的预测

2025-01-070
PRE